Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Skin Substitutes in Mohs Surgery Patients
Description
Doctor Luke Vidge, a Mohs surgeon at Vitality Skin Care in Austin, TX, discussed the application of skin substitutes, particularly placental-based allografts, in patients undergoing Mohs surgery. His interest began after witnessing the challenges faced by patients, like an elderly woman wanting to enjoy her summer post-surgery. Through clinical experiences, he observed that traditional healing methods sometimes resulted in prolonged recovery and pain. The use of placental allografts has shown remarkable benefits, promoting healing in patients with various comorbidities by reducing inflammation and enhancing recovery time. These allografts, which contain a rich array of growth factors and cytokines, help stimulate cellular activity and improve outcomes in challenging cases. Vidge detailed multiple case studies where patients experienced fast healing and satisfaction, even those with significant medical histories. He highlighted the scientific mechanisms behind the allografts, such as their influence on stem cell migration and scar formation. Although he advocates for cautious use and acknowledges the costs associated with these treatments, Vidge emphasizes their role in improving patient care and outcomes, particularly in those considered poor surgical candidates. Overall, he presents a strong case for integrating placental allografts as a viable option in postoperative care for Mohs surgery patients, contingent on individual needs and clinical judgment.
View moreConclusions
- Skin substitutes, particularly placental-derived allografts, can significantly enhance healing in patients with chronic wounds and those at high risk for poor surgical outcomes.
- The study highlights the importance of understanding the specific contents of skin substitutes, as the chorion layer contains more beneficial growth factors than the amnion layer.
- Treatment with dehydrated human amnion chorion membrane (DHACM) promotes cell migration, collagen deposition, and reduces pro-inflammatory cytokine levels.
- DHACM and lyophilized human amnion chorion membrane (LHACM) have been shown to regulate the TGF-β signaling pathway, which is crucial in fibrotic healing processes.
- Patients treated with DHACM have reported higher satisfaction levels due to faster healing and less pain compared to traditional wound care methods.
- Amniotic membrane allografts demonstrate potential in preventing excessive scarring and improving overall quality of healing by modulating the extracellular matrix environment.
- The findings indicate that the application of skin substitutes can be particularly beneficial for older patients or individuals with multiple comorbidities, who are generally at higher risk of complications.
- Koob TJ, et al. J Biomed Mater Res B Appl Biomater. 2015 Jul;103(5):1133-1140.
- Koob TJ, et al. Int Wound J. 2013 Oct;10(5):493-500.
- Koob TJ, et al. Vasc Cell. 2014 May 1;6:10.
- Maan ZN, et al. J Surg Res. 2015 Feb;193(2):953-962.
- Willett NJ, et al. Arthritis Res Ther. 2014 Feb 6;16(1):R47.
- Massee M, et al. J Biomed Mater Res B Appl Biomater. 2016 Oct;104(7):1495-1503.
- Moreno SE, et al. J Biomed Mater Res B Appl Biomater. 2022;110(4):731-742.
- Massee M, et al. Adv Wound Care (New Rochelle). 2016 Feb 1;5(2):43-54.
- Lei J, et al. Adv Wound Care. 2017;6(2):43-53.
- Lim JJ, et al. Perinatal Stem Cells: Research and Therapy. 2018:157-174.
- Moreno SE, et al. Sci Rep 14, 15998 (2024).